Skip to main content
OpenTrials

Clinical trial condition

Overactive Bladder

Explore clinical trials studying Overactive Bladder. Study availability and eligibility vary by location and protocol.

363 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Overactive Bladder trial results

Completed

FREEOAB Study for Overactive Bladder

NCT04547920

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +14 more
Locations
  • Stanford University Stanford, California, United States
  • The Pelvic Solutions Center Denver, Colorado, United States
  • Colorado Pelvic Floor Consultants Englewood, Colorado, United States
  • Women's Health Institute Oak Lawn, Illinois, United States
View Trial Details
Completed

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

NCT05783219

Conditions
Digestive System Diseases, Fecal Incontinence, Female Urogenital Diseases, +18 more
Locations
  • ULP Female Pelvic Medicine and Reconstructive Surgery - Springs Medical Center Suite 190 Louisville, Kentucky, United States
  • ULP Female Pelvic Medicine and Reconstructive Surgery - Urogynecology Associates office Louisville, Kentucky, United States
View Trial Details
Completed

Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)

NCT05067478

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • 43rd Medical Associates Phoenix, Arizona, United States
  • Fiel Family and Sports Medicine, PC Tempe, Arizona, United States
  • Arkansas Urology Associates, PA Little Rock, Arkansas, United States
View all 64 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

NCT02757768

Conditions
Benign Prostatic Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Site US01009 Homewood, Alabama, United States
  • Site US01005 Huntsville, Alabama, United States
  • Site US01012 Anchorage, Alaska, United States
  • Site US01070 Hawaiian Gardens, California, United States
View all 79 locations
View Trial Details
Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

NCT02656173

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
Locations
  • Site JP81046 Aichi, Japan
  • Site JP81009 Chiba, Japan
  • Site JP81045 Chiba, Japan
  • Site JP81041 Fukuoka, Japan
View all 58 locations
View Trial Details
Completed

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder

NCT01972841

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +15 more
Locations
  • Site US10049 Coastal Clinical Research, Inc. Mobile, Alabama, United States
  • Site US10112 TFI, LLC Mobile, Alabama, United States
  • Site US10104 Clinical Research Advantage, Inc. Chandler, Arizona, United States
  • Site US10021 Beach Clinical Studies Phoenix, Arizona, United States
View all 435 locations
View Trial Details

Related conditions